Melinta Therapeutics Inc. buy marge
Start price
23.07.15
/
50%
€973.60
Target price
18.07.16
€1,127.5
Performance (%)
-57.22%
End price
18.07.16
€416.50
Summary
This prediction ended on 18.07.16 with a price of €416.50. The BUY prediction by marge for Melinta Therapeutics Inc. performed very badly with a performance of -57.22%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by marge for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
Cempra
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)
Stopped prediction by marge for Melinta Therapeutics Inc.
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€174.76
02.11.16
02.11.16
€405.90
02.05.17
02.05.17
-48.06%
02.05.17
02.05.17
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€756.35
21.06.15
21.06.15
€1,000.00
21.07.15
21.07.15
35.72%
21.07.15
21.07.15